Telemedicine has obvious cost and access advantages, but regulatory and other issues have stymied its rapid growth. A research letter in the Journal of the American Medical Association quantifies its growth in one large national health plan company with a substantial commercial and Medicare Advantage population. (JAMA Letter) Trends in telemedicine use were tracked from 2005 through 2017. The population used for the analysis is younger and somewhat more concentrated in the South than is the entire US population. Over the entire study period, there were about 384,000 telemedicine visits by 217,851 patients. But there were only 206 visits in 2005 and over 202,000 in 2017. The compounded annual growth rate in visits was 52% from 2005 through 2014 and 261% from 2015 to 2017, a period when more states began requiring equal coverage of telemedicine and many payers began to encourage use of telehealth. In the latter period the average age of users was around 38, 63% were female and 83% lived in urban areas. Over the complete study period, 53% of visits were for mental health issues, 39% were for primary care and the remainder were specialty visits. Both tele-mental health and primary care visits experienced rapid growth, particularly in recent years, and by 2017 primary care visits were the most common use of telemedicine. Tele-mental health visits increased faster in areas with no psychiatrists and in states with telehealth legislation. Primary care visits did not appear to be associated with physician supply in a geographic area or with telehealth parity laws. It is a positive development that telemedicine use appears to finally be growing more rapidly, as it generally delivers equivalent quality at lower prices and allows people with limited provider supply near where the live to access more clinicians.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace